Intra-amniotic methotrexate versus CO2 laser laparoscopic salpingotomy in the management of tubal ectopic pregnancy—a prospective randomized trial

1994 ◽  
Vol 62 (4) ◽  
pp. 876-878 ◽  
Author(s):  
Robert T. O’Shea ◽  
Graeme R. Thompson ◽  
Angela Harding
Keyword(s):  
Randomized Trial ◽  
Ectopic Pregnancy ◽  
Co2 Laser ◽  
Prospective Randomized Trial ◽  
Tubal Ectopic Pregnancy

scholarly journals Molecular therapy for ectopic pregnancy

2019 ◽  
Vol 2 (2) ◽  
pp. 38-39
Author(s):  
Agus Cakhantara ◽  
Aditya Prabawa
Keyword(s):  
Cell Death ◽  
Literature Review ◽  
Randomized Trial ◽  
Ectopic Pregnancy ◽  
Molecular Target ◽  
Therapeutic Use ◽  
Molecular Therapy ◽  
Tubal Ectopic Pregnancy ◽  
Placental Cell ◽  
Ectopic Pregnancies

Objective : To compare treatment in ectopic pregnancy within combination gefitinib, methotrexat and methotrexat only Method : Literature Review Result : Ectopic pregnancies are serious condition that can be fatal, therefore the prompt therapeutic is essential. There some recent studies explain molecular target therapeutic use combination of gefitinib and methotrexat is more effective inducing placental cell death and can rapidly resolve tubal ectopic pregnancy than methotrexate only. If a large clinical randomized trial confirm these finding, these combination could become a new medical option for ectopic pregnancy Conclusion : Combination gefitinib and methotrexate is more effective in ectopic pregnancy than methotrexate only

Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial

2014 ◽  
Vol 291 (4) ◽  
pp. 939-943 ◽  
Author(s):  
Priscila Matthiesen Silva ◽  
Edward Araujo Júnior ◽  
Gustavo Nardini Cecchino ◽  
Julio Elito Júnior ◽  
Luiz Camano
Keyword(s):  
Randomized Trial ◽  
Ectopic Pregnancy ◽  
Expectant Management ◽  
Double Blind ◽  
Tubal Ectopic Pregnancy
Sign in / Sign up

Export Citation Format

Share Document